Uvax Bio Appoints Pedro Garbes, MD., as Vice President, Global Medical Lead
WILMINGTON, Del.--(BUSINESS WIRE)--Uvax Bio LLC, a vaccine biotechnology company that utilizes its proprietary 1c-SApNP® vaccine design and manufacturing platform to produce protein-based VLP vaccines to fight viruses that threaten global health, announced today that Pedro Garbes, MD., has joined the company as Vice...